pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

HERITAGE

USupdated 5mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(1)

pipeline depth1 products
Unknown: 1
1Unknown
drug
GLIPIZIDE AND METFORMIN HCL

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →
🐶 Hiring Signal
No open roles indexed yet — view HERITAGE jobs →

News

  • Flagship brings 3 biotech platforms together to launch AI drug discovery player Etcelera
    Flagship Pioneering unveiled Etcelera today, a new AI-powered biotech emerging from stealth that aims to predict how potential medicines will act in patients.
    fiercebiotech · 3d ago
  • Backed by Amish and Mennonites, a new kind of gene therapy company takes shape
    LANCASTER, PA — This spring, Lorraine and Mark Martin, a Mennonite family with a tax business, adopted a stubby-legged cow named Royal Lite. Lorraine, Mark and Royal Lite all have one thing in comm…
    endpoints · 4d ago
  • Opinion: Is Milton Friedman to blame for America’s health care woes?
    Health policy experts John McDonough and Stuart Butler debate where the U.S. medical system went wrong — and how to fix it.
    stat · 16d ago
  • Eli Lilly and the LA Dodgers: A tale of 2 dynasties
    Watching the baseball playoffs this week, I was struck by the parallels between the Los Angeles Dodgers and Eli Lilly. Both franchises spend a lot of money and always appear to come out on top.
    biospace · 23d ago
  • Opinion: Doctors should educate patients about ‘Asian glow’ and drinking risks
    It wasn’t until he started medical school, Brian Zhang writes, that he realized ‘Asian glow’ from drinking was a sign of something important.
    stat · 1mo ago
  • 'Still a bull': Novo's CEO on honoring heritage and planning for the future amid corporate rebrand
    Novo CEO Mike Doustdar—tapped to breathe new life into the Danish drugmaker last year after losing GLP-1 marketing ground to chief rival Eli Lilly—isn’t one to make changes for the sake of change.
    fiercebiotech · 1mo ago
  • Businesses can now apply for NIH funding
    RFK Jr. to speak at Children's Health Defense conference, how to protect your heart in outer space, and more health news
    stat · 1mo ago
  • Opinion: 8 steps to making surrogacy more ethical for everyone involved
    “Everything about the West case shows how miserably surrogacy has been managed in America,” writes Arthur Caplan.
    stat · 2mo ago
  • Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
    Bagsværd, Denmark, 6 August 2026 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated per…
    globenewswire_health · 2mo ago
  • Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
    Bagsværd, Denmark, 6 August 2026 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated per…
    globenewswire_health · 2mo ago
view all news mentions →
identifiers
country
US
source
openfda_drugsfda
mentioned in
10news items
entity-linker matched

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?